Psychotic Disorder Not Otherwise Specified
📧 Sign up to get email alerts when something new happens for Psychotic Disorder Not Otherwise Specified.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Randomized Double Blind Placebo Control Study in Patients with Schizophrenia [Phase 2]
Phase 2 randomized double-blind placebo-controlled trial in schizophrenia and related psychotic disorders has completed; sponsor: Pakistan I…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain [Phase 2]
Phase 2 trial evaluating betahistine for efficacy and tolerability in reducing antipsychotic-associated weight gain; the study is completed …
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Optimizing Response in Psychosis Study [Phase 4]
Phase 4 clinical trial update for an Optimizing Response in Psychosis study indicates the trial was terminated with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
This update reports results from a youth-focused trial evaluating the effectiveness and tolerability of a second-generation antipsychotic ac…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Schizophrenic Patients Taking Part in Integrated Care Program
The AstraZeneca-sponsored clinical trial involving schizophrenia and related psychotic disorders has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.